<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2017">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05134909</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00003195</org_study_id>
    <nct_id>NCT05134909</nct_id>
  </id_info>
  <brief_title>Customized Contact Lenses</brief_title>
  <official_title>Custom Vision-Corrective Lens Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Houston</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall goal of this project is to improve the visual quality of individuals who have&#xD;
      abnormal corneal conditions that alter the shape of their cornea (eg. keratoconus). Patients&#xD;
      with an abnormal corneal shape have substantial lower and higher order aberrations&#xD;
      (distortions in the eye). This results in reduced visual acuity which cannot be corrected by&#xD;
      regular sphero-cylindrical correction. Compensating for these aberrations has been&#xD;
      challenging due to difficulty measuring their wavefront aberrations accurately and,&#xD;
      consequently, manufacturing the custom contact lenses with irregular optical profiles. This&#xD;
      project is designed to systematically overcome these obstacles with a customized scleral&#xD;
      and/or soft contact lens capable of compensating for the lower and higher order aberrations&#xD;
      of the eye.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">March 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>up to 2 months</time_frame>
    <description>Snellen &quot;Tumbling E&quot; method will be used to determine the smallest visible letter that a subject can see.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Contrast sensitivity</measure>
    <time_frame>up to 2 months</time_frame>
    <description>Light and dark sinusoidal stripes (Gabor gratings) will used to determine the smallest contrast that a subject can see.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Keratoconus</condition>
  <arm_group>
    <arm_group_label>Study: Keratoconus</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Customized contact lenses will be fitted to each study subject based on their own optical defects.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Customized contact lens</intervention_name>
    <description>The customized lenses are designed to correct the eye's optical aberrations.</description>
    <arm_group_label>Study: Keratoconus</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Able to read and understand the informed consent document in English&#xD;
&#xD;
          -  18 to 75 years of age&#xD;
&#xD;
          -  Received diagnosis of keratoconus by a clinician&#xD;
&#xD;
          -  Willing and able to follow instructions&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Has best corrected visual acuity of 20/20 or better in the keratoconic eye(s).&#xD;
&#xD;
          -  Normal/typical subjects&#xD;
&#xD;
          -  Is unable to handle, insert, remove or care for the study lenses.&#xD;
&#xD;
          -  Has any active anterior segment disease, pathology, or surgery affecting vision,&#xD;
             refraction, or the ability to wear a contact lens&#xD;
&#xD;
          -  History of ocular pharmacological treatment&#xD;
&#xD;
          -  History of ocular trauma or surgery causing abnormal corneal curvature or distorted&#xD;
             vision History of contact lens intolerance&#xD;
&#xD;
          -  Pregnant at the time of enrollment in the study (self-reported- It has been shown&#xD;
             hormonal changes during pregnancy may affect corneal biomechanics negatively)&#xD;
&#xD;
          -  Adults unable to consent&#xD;
&#xD;
          -  Individuals who are not yet adults (infants, children, teenagers under the age of 18&#xD;
             because it has been shown the average age of the appearance of Keratoconus is the&#xD;
             second decade of life ( 15-18 years of age)&#xD;
&#xD;
          -  Prisoners&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Geunyoung Yoon, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Houston</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Geunyoung Yoon, PhD</last_name>
    <phone>7137437860</phone>
    <email>gyoon2@central.uh.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ayeswarya Ravikumar, PhD</last_name>
    <phone>7137431637</phone>
    <email>aravikum@central.UH.EDU</email>
  </overall_contact_backup>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 11, 2021</study_first_submitted>
  <study_first_submitted_qc>November 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 26, 2021</study_first_posted>
  <last_update_submitted>November 23, 2021</last_update_submitted>
  <last_update_submitted_qc>November 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Houston</investigator_affiliation>
    <investigator_full_name>Geunyoung Yoon</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

